Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
Open Access
- 1 January 2018
- journal article
- research article
- Published by Medknow in Journal of Global Infectious Diseases
- Vol. 10 (1) , 19-21
Abstract
Urinary tract infection (UTI) is a common and painful human illness that, unfortunately not responsive to commonly used antibiotics in current practice. The role of fosfomycin and nitrofurantoin in the era of growing bacteria resistance has been widely discussed. In this study, we aimed to know the local antimicrobial susceptibilities, fosfomycin and nitrofurantoin susceptibility in particular, for urinary extended-spectrum-beta-lactamase-producing Escherichia coli and Escherichia pneumoniae (ESBL-EC and ESBL-KP) isolates in our hospital. We collected 464 urine isolates, including 384 ESBL-EC and 80 ESBL-KP isolates. Of 464 urine isolates culture positive ESBL-UTIs, EC caused 384 (82.75%), followed by Klebsiella in 80 (17.24%). Carbapenems and Colistin seems to remain as the first line therapy for the majority of ESBL-UTIs in the local setting. Colistin and fosfomycin remains the most sensitive antibiotic while nitrofurantoin still preserves the good sensitivity against ESBL and found to be an only oral sensitive antibiotic.Keywords
This publication has 16 references indexed in Scilit:
- Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implicationsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- [Are there alternatives to antimicrobial therapy and prophylaxis of uncomplicated urinary tract infections?]2016
- Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New ZealandInternational Journal of Antimicrobial Agents, 2009
- Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece.2008
- Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypesDiagnostic Microbiology and Infectious Disease, 2007
- In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum β-lactamase–producing Escherichia coli isolated from urine and bloodDiagnostic Microbiology and Infectious Disease, 2007
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Evidence That the Fosfomycin Target Cys115 in UDP-N-acetylglucosamine Enolpyruvyl Transferase (MurA) Is Essential for Product ReleaseJournal of Biological Chemistry, 2005
- Emerging antibiotic resistance in urinary tract pathogensInfectious Disease Clinics of North America, 2003
- Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University HospitalJournal of Antimicrobial Chemotherapy, 2002